News and Views

The findings from the Cravatt lab reveal human proteins are better drug targets than previously thought.

The Davis lab study reveals possible strategy for treating memory disorders such as Alzheimer’s disease.

The new drug candidate from the Disney lab shows potential in treating spinocerebellar ataxia, a currently incurable disease.

The Wyatt lab’s HIV-like nanoparticles trigger a promising immune response.

The grant supports work in the Griffin and Kamenecka labs to develop novel compounds to enhance immunity in patients with cancer.

Skaggs Family Gives $2 Million for New TSRI Graduate Program Endowment
Harnessing Nature's Vast Array of Venoms for Drug Discovery
TSRI Celebrates 24th Commencement
Researchers Pioneer a Breakthrough Approach to Breast Cancer Treatment
Scientists Design Potent Therapeutic ‘Warheads’ That Target Cancer Cells
Team Streamlines Biomedical Research by Making Genetic Data Easier to Search
'An Excellent Time for Neuroscience': An Interview with Hollis Cline
Scientists Find Root Cause of Appetite Loss During Illness
New Method Enlists Electricity for Easier, Cheaper, Greener Chemistry
Scientists Reveal Secrets of a Deadly Virus Family
Team Predicts Cell Changes that Affect Breast Cancer Growth
Wellderly Study Suggests Link Between Genes that Protect Brain Health and Overall Healthy Aging
New Molecule-Building Method Opens Up Vast Realm of Chemistry for Pharma and Other Industries
New Project Helps Researchers Build a Biomedical Knowledgebase
Scientists Get First-Ever Glimpse of 'Teenage' HIV-Neutralizing Antibody
Facing an Opioid Epidemic